Navigation Links
Bionovo to Present Positive Results from Phase 2 Trial of Menerba for Vasomotor Symptoms to the International Community
Date:9/3/2009

body mass index and weight compared to those on placebo.

"The novel mechanism of action, the positive efficacy results and the excellent safety profile, make Menerba an extremely promising drug candidate for postmenopausal women. While 40 million women in the United States suffer from hot flashes and night sweats leading to the second largest indication in Women's Health domestically, the opportunity is significantly increased when we factor in international opportunities. We look forward to introducing Menerba to a wider scientific, clinical and pharmaceutical community, where there is demonstrated interest in finding an alternative to hormone therapy on an international basis," said Dr. Mary Tagliaferri, M.D., President and Chief Medical Officer at Bionovo.

"I am very encouraged by the findings of this clinical trial. The novel mechanism of action and phase 2 efficacy and safety results are encouraging and warrant further investigation. Presuming the phase 3 results confirm the findings in the phase 2 trial, there seems no question that, if approved, Menerba's safety and efficacy profile could make it a first line therapy in an indication that clearly needs alternatives," said Wulf Utian, M.D., Ph.D., D.Sc., founder and President Emeritus of the North American Menopause Society and Menerba's phase 3 Principal Clinical Investigator.

Menerba

Menerba is an estrogen receptor (ER) beta selective drug developed as an alternative to postmenopausal hormone products currently on the market, which are both ER beta and ER alpha agonists that have been shown to increase the risk for breast and uterine cancers. It has been shown that the increased risk of breast and uterine cancers is associated with ER alpha activation and that ER beta blocks the growth promoting effects on breast cancer cells. Bionovo recognized the opportunity to commercialize a product that would be equally effective
'/>"/>

SOURCE Bionovo, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Bionovo Presents Positive Results from Phase 1B Trial of Bezielle for Metastatic Breast Cancer
2. Bionovo to Present at the BMO Capital Markets Ninth Annual Focus on Healthcare Conference
3. Bionovo Announces Arbitration Decision in Lawsuit Filed by Former Officer - All Claims Denied
4. Bionovo, Inc. to Announce First Quarter Fiscal Year 2009 Financial Results on Thursday, May 7, 2009
5. Bionovo to Present at the Cambria Capital Investor Meeting
6. Bionovo to Present at Wall Street Analyst Forums 20th Annual Institutional Investor Conference
7. Bionovo, Inc. to Announce Fourth Quarter and Year-End Financial Results on Thursday, March 12, 2009
8. Jan Ake Gustafsson, M.D., Ph.D., Joins Bionovos Scientific Advisory Board
9. Bionovo Announces Presentation at the National Cancer Institute
10. Bionovo Announces Cost Control Measures Taken
11. Willa A. Hsueh, M.D., Joins Bionovos Scientific Advisory Board
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/30/2014)... Florida (PRWEB) October 30, 2014 Timothy, ... visit to Pompano Beach firefighters, showing that you are ... , Timothy met firefighters Tracey and Carl at ... Galuppi’s Restaurant and the Pompano Beach Chamber of Commerce. ... the fire truck, letting Timothy wear his real fireman’s ...
(Date:10/30/2014)... High efficacy and low irritation ... medical-grade skin care domain: Cosmederm, the specialty biotechnology ... topical dermatological products, today announces the launch of ... patented COSMEDERM®-7 anti-irritant technology. , Formulated with ... 70%) and a low pH (pH 1.2 and ...
(Date:10/30/2014)... (PRWEB) October 30, 2014 Paramount Rx, ... care, is increasing efforts to help people save money ... continue to increase for prescription drugs in the new ... savings and resources to bridge the relationship between consumers, ... of the biggest challenges people face today with medical ...
(Date:10/30/2014)... HealthDay Reporter , WEDNESDAY, ... genes have been identified that appear linked to autism ... say they are on their way to discovering up ... disorder. Autism spectrum disorders include a range of ... repetitive behaviors. An estimated one in 68 U.S. children ...
(Date:10/30/2014)... 2014 Dr. Joseph Furlin MD, a certified ... his practices; OB GYN in Melrose Park, IL ... website contains important information about each of the care services ... patient forms in English and Spanish. The navigation of ... on the website provide Dr. Furlin’s patients with important information ...
Breaking Medicine News(10 mins):Health News:4-year-old InstaKNOT CEO Honors Local Firefighters with Community Support 2Health News:4-year-old InstaKNOT CEO Honors Local Firefighters with Community Support 3Health News:4-year-old InstaKNOT CEO Honors Local Firefighters with Community Support 4Health News:Cosmederm Redefines Peel Science Standard with Launch of Refinity® Skin Health System 2Health News:Cosmederm Redefines Peel Science Standard with Launch of Refinity® Skin Health System 3Health News:Cosmederm Redefines Peel Science Standard with Launch of Refinity® Skin Health System 4Health News:Paramount Rx Discount Card Program Provides Valuable Resources in Midst of Current Health Care Reform 2Health News:Paramount Rx Discount Card Program Provides Valuable Resources in Midst of Current Health Care Reform 3Health News:Discovery of 100-Plus Genes Tied to Autism May Improve Treatments 2Health News:Discovery of 100-Plus Genes Tied to Autism May Improve Treatments 3Health News:Dr. Joseph Furlin Launches New Website with Information about Care Services 2
... , , Cuts Will ... to Recent Cuts , , ... Chairman Max Baucus (D-Mont.) issued his recommendations for healthcare reform in ... bill contains several provisions that affect home medical equipment, ranging from ...
... remain unknown, expert says, , WEDNESDAY, Sept. 16 (HealthDay News) ... for older women: stopping hot flashes. , In a ... the New England Journal of Medicine , researchers from ... cetrorelix (Cetrotide) helped ease hot flash symptoms. , "It ...
... obesity, but beverage industry balks at proposal , WEDNESDAY, Sept. ... per ounce of soda and other sugary drinks could stem ... first year alone, health experts say. , That windfall could ... to prevent obesity, say a group of prominent researchers in ...
... , NEW YORK, Sept. 16 As ... If the thought of skinny jeans has you feeling uneasy, think ... you into those new jeans. , , Listen ... , , Registered journalists can access video, audio, ...
... , , MINNEAPOLIS, Sept. 16 ... Board Members and thanked outgoing members for their service to the ... was elected as the new Board Chair. The full roster of ... David Fisher, Board Chair - ...
... , THE GLOBALIZATION PLATFORM ... More than 120 delegates, including heads of state, acclaimed artists, Nobel ... City for the fourth annual Global Creative Leadership Summit , ... globalization. Organized by the Louise Blouin Foundation , an international ...
Cached Medicine News:Health News:Senate Finance Committee Cuts Home Medical Equipment in Reform Package 2Health News:Fertility Drug Shows Potential Against Hot Flashes 2Health News:Fertility Drug Shows Potential Against Hot Flashes 3Health News:'Soda Tax' Wins Health Experts' Support 2Health News:'Soda Tax' Wins Health Experts' Support 3Health News:'Soda Tax' Wins Health Experts' Support 4Health News:ClearWay Minnesota(SM) Board Approves New Officers 2Health News:Global Creative Leadership Summit 23-25 September 2009 2Health News:Global Creative Leadership Summit 23-25 September 2009 3
(Date:10/30/2014)... YORK , Oct. 30, 2014  The number ... States is growing steadily, thanks to drug ... as a result of the economic downturn, retail clinic ... a year of opportunities, as the number of retail ... researcher,s report, Retail Clinics Market Overview and 2014 ...
(Date:10/30/2014)... Molecular Profiles Ltd., a subsidiary of Columbia ... Maryland -based Xceleron have announced a collaboration ... development that will be launched at AAPS in ... This partnership extends Molecular Profiles, new ROADMAP to Clinical ... month. The company also has complementary collaborations in place ...
(Date:10/30/2014)... LOS ANGELES , Oct. 30, 2014 /PRNewswire/ ... biopharmaceutical research and development company specializing in oncology, ... technology and its lead drug candidate, aldoxorubicin.  The ... A New Approach," will be given by ... the Sarcoma Oncology Center and principal investigator of ...
Breaking Medicine Technology:Report: Drugstore Chains Drive Retail Clinic Growth 2Report: Drugstore Chains Drive Retail Clinic Growth 3Molecular Profiles To Launch US Strategic Alliance At AAPS 2Molecular Profiles To Launch US Strategic Alliance At AAPS 3CytRx Announces Oral Presentation at 2014 Chemotherapy Foundation Symposium 2CytRx Announces Oral Presentation at 2014 Chemotherapy Foundation Symposium 3CytRx Announces Oral Presentation at 2014 Chemotherapy Foundation Symposium 4
... AVANIR Pharmaceuticals, Inc. (Nasdaq: AVNR ) ... for the quarter ended December 31, 2010 before market ... and Chief Executive Officer, Randall Kaye, M.D., Senior Vice ... President, Finance, will host an investment community conference call ...
... 27, 2011 Higher volume drove four ... in Q4 led to growth in operating income. ... (non-GAAP). Full-year 2010 revenue topped $23 billion as ... exceed $1 billion in annual sales. Full-year 2010 ...
Cached Medicine Technology:Lilly Reports Fourth-Quarter and Full-Year 2010 Results, Provides 2011 Financial Guidance 2Lilly Reports Fourth-Quarter and Full-Year 2010 Results, Provides 2011 Financial Guidance 3Lilly Reports Fourth-Quarter and Full-Year 2010 Results, Provides 2011 Financial Guidance 4Lilly Reports Fourth-Quarter and Full-Year 2010 Results, Provides 2011 Financial Guidance 5Lilly Reports Fourth-Quarter and Full-Year 2010 Results, Provides 2011 Financial Guidance 6Lilly Reports Fourth-Quarter and Full-Year 2010 Results, Provides 2011 Financial Guidance 7Lilly Reports Fourth-Quarter and Full-Year 2010 Results, Provides 2011 Financial Guidance 8Lilly Reports Fourth-Quarter and Full-Year 2010 Results, Provides 2011 Financial Guidance 9Lilly Reports Fourth-Quarter and Full-Year 2010 Results, Provides 2011 Financial Guidance 10Lilly Reports Fourth-Quarter and Full-Year 2010 Results, Provides 2011 Financial Guidance 11Lilly Reports Fourth-Quarter and Full-Year 2010 Results, Provides 2011 Financial Guidance 12Lilly Reports Fourth-Quarter and Full-Year 2010 Results, Provides 2011 Financial Guidance 13Lilly Reports Fourth-Quarter and Full-Year 2010 Results, Provides 2011 Financial Guidance 14Lilly Reports Fourth-Quarter and Full-Year 2010 Results, Provides 2011 Financial Guidance 15Lilly Reports Fourth-Quarter and Full-Year 2010 Results, Provides 2011 Financial Guidance 16Lilly Reports Fourth-Quarter and Full-Year 2010 Results, Provides 2011 Financial Guidance 17Lilly Reports Fourth-Quarter and Full-Year 2010 Results, Provides 2011 Financial Guidance 18Lilly Reports Fourth-Quarter and Full-Year 2010 Results, Provides 2011 Financial Guidance 19Lilly Reports Fourth-Quarter and Full-Year 2010 Results, Provides 2011 Financial Guidance 20Lilly Reports Fourth-Quarter and Full-Year 2010 Results, Provides 2011 Financial Guidance 21
For accurately monitoring core temperature and heart and breath sounds....
For accurately monitoring core temperature and heart and breath sounds....
... The bodys warmth beneath drapes. The life-giving ... are yours to guard, measure, stabilize and ... products helps you do your job, giving ... most comfortable and precise management of your ...
... Level 1 enables hospitals ... patient monitors to a ... Our temperature monitoring disposale ... are superior in their ...
Medicine Products: